Tenax Therapeutics (TENX) Tops Q3 EPS by 6c

Tenax Therapeutics (NASDAQ: TENX) reported Q3 EPS of ($0.10), $0.06 better than the analyst estimate of ($0.16).

For earnings history and earnings-related data on Tenax Therapeutics (TENX) click here.

You May Also Be Interested In

• Meta capex to surge in 2027, neocloud fears ’erroneous’ - SemiAnalysis
• Exyn Technologies reports Q1 2026 results after Nasdaq IPO
• Morgan Stanley Comments on Tesla (TSLA) Miam Robotaxi Launch